Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT04885647 |
| Consolidated Lead Sponsor | Xiamen Amoytop Biotech Co |
| Therapeutic Condition Cohort | Gastroenterology, Hepatology, and Renal |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | COMPLETED |
| Registered Enrollment | 60 participants (ACTUAL) |
| Registered Start Date | 2021-03-12 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| The Second Affiliated Hospital of Chongqing Medical University | Chongqing, China | Open Hospital Dossier -> |
| The First Affiliated Hospital of Guangzhou Medical University | Guangzhou, China | Open Hospital Dossier -> |
| The Third Xiangya Hospital of Central South University | Changsha, China | Open Hospital Dossier -> |
| Xiangya Hospital Central South University | Changsha, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Gastroenterology, Hepatology, and Renal Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.